DE69738597D1 - Vakzine gegen das varicella zostervirus produkt von gen 63 - Google Patents

Vakzine gegen das varicella zostervirus produkt von gen 63

Info

Publication number
DE69738597D1
DE69738597D1 DE69738597T DE69738597T DE69738597D1 DE 69738597 D1 DE69738597 D1 DE 69738597D1 DE 69738597 T DE69738597 T DE 69738597T DE 69738597 T DE69738597 T DE 69738597T DE 69738597 D1 DE69738597 D1 DE 69738597D1
Authority
DE
Germany
Prior art keywords
zostervirus
vakzine
varicella
gen
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69738597T
Other languages
English (en)
Other versions
DE69738597T2 (de
Inventor
Bernard Rentier
Catherine Sadzot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Liege
GlaxoSmithKline Biologicals SA
Original Assignee
Universite de Liege
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602617.4A external-priority patent/GB9602617D0/en
Priority claimed from GBGB9626882.6A external-priority patent/GB9626882D0/en
Application filed by Universite de Liege, GlaxoSmithKline Biologicals SA filed Critical Universite de Liege
Application granted granted Critical
Publication of DE69738597D1 publication Critical patent/DE69738597D1/de
Publication of DE69738597T2 publication Critical patent/DE69738597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69738597T 1996-02-09 1997-02-04 Vakzine gegen das varicella zostervirus produkt von gen 63 Expired - Fee Related DE69738597T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9602617 1996-02-09
GBGB9602617.4A GB9602617D0 (en) 1996-02-09 1996-02-09 Vaccines
GBGB9626882.6A GB9626882D0 (en) 1996-12-24 1996-12-24 Vaccines
GB9626882 1996-12-24
PCT/EP1997/000520 WO1997028820A1 (en) 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product

Publications (2)

Publication Number Publication Date
DE69738597D1 true DE69738597D1 (de) 2008-05-08
DE69738597T2 DE69738597T2 (de) 2008-07-24

Family

ID=26308641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738597T Expired - Fee Related DE69738597T2 (de) 1996-02-09 1997-02-04 Vakzine gegen das varicella zostervirus produkt von gen 63

Country Status (20)

Country Link
EP (1) EP0879060B1 (de)
JP (1) JP2002504080A (de)
KR (1) KR100365986B1 (de)
CN (1) CN1210470A (de)
AR (1) AR005750A1 (de)
AT (1) ATE390146T1 (de)
AU (1) AU723555B2 (de)
BR (1) BR9707400A (de)
CA (1) CA2245545C (de)
CZ (1) CZ289971B6 (de)
DE (1) DE69738597T2 (de)
ES (1) ES2301175T3 (de)
HU (1) HUP0001991A3 (de)
IL (1) IL125440A (de)
NO (1) NO983617L (de)
NZ (1) NZ331164A (de)
PL (1) PL188457B1 (de)
TR (1) TR199801531T2 (de)
TW (1) TW575427B (de)
WO (1) WO1997028820A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2298316T3 (es) * 1997-09-05 2008-05-16 Glaxosmithkline Biologicals S.A. Emulsiones de aceite en agua que contienen saponinas.
CA2324289C (en) * 1998-03-09 2010-07-13 Smithkline Beecham Biologicals S.A. Combined vaccine compositions
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
ATE374622T1 (de) * 1999-11-03 2007-10-15 Powderject Vaccines Inc Genetische impstoffe mit adjuvans
DK1650221T3 (da) 2000-02-23 2012-09-03 Glaxosmithkline Biolog Sa Nye forbindelser
US8916514B2 (en) 2009-05-27 2014-12-23 Glaxosmithkline Biologicals, S.A. CASB7439 constructs
AU2014214844B2 (en) 2013-02-07 2017-12-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
WO2023039223A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines
CN114891830B (zh) * 2022-04-02 2024-03-01 武汉博沃生物科技有限公司 基于水痘-带状疱疹病毒的重组表达载体、重组病毒及用途
CN117224664B (zh) * 2023-10-23 2024-05-24 简达生物医药(南京)有限公司 一种重组带状疱疹疫苗注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
ES2071770T3 (es) * 1989-06-27 1995-07-01 Smithkline Beecham Biolog Nuevos compuestos.

Also Published As

Publication number Publication date
WO1997028820A1 (en) 1997-08-14
EP0879060A1 (de) 1998-11-25
TR199801531T2 (xx) 1998-10-21
TW575427B (en) 2004-02-11
DE69738597T2 (de) 2008-07-24
KR19990082360A (ko) 1999-11-25
EP0879060B1 (de) 2008-03-26
IL125440A0 (en) 1999-03-12
CA2245545A1 (en) 1997-08-14
CZ248698A3 (cs) 1998-12-16
NO983617L (no) 1998-10-02
ES2301175T3 (es) 2008-06-16
AU1601297A (en) 1997-08-28
PL328414A1 (en) 1999-01-18
CA2245545C (en) 2008-12-30
NO983617D0 (no) 1998-08-06
CZ289971B6 (cs) 2002-05-15
IL125440A (en) 2002-02-10
HUP0001991A2 (hu) 2000-10-28
JP2002504080A (ja) 2002-02-05
KR100365986B1 (ko) 2003-02-20
HUP0001991A3 (en) 2003-08-28
NZ331164A (en) 2000-02-28
AR005750A1 (es) 1999-07-14
BR9707400A (pt) 2000-01-04
CN1210470A (zh) 1999-03-10
PL188457B1 (pl) 2005-02-28
AU723555B2 (en) 2000-08-31
ATE390146T1 (de) 2008-04-15

Similar Documents

Publication Publication Date Title
DE69822463D1 (de) Regulation der expression von chinolatphosphoribosyltransferase
DE69733249T8 (de) Bestimmung der genauen position von endoskopen
DK72793D0 (da) Nyt produkt
NO960482L (no) Skosåle
DE69426294D1 (de) Rehydrierbares produkt
DE69709613D1 (de) Schminkdose
DE69738597D1 (de) Vakzine gegen das varicella zostervirus produkt von gen 63
FI962499A (fi) Herbisidien tehon parantaminen
FI943891A0 (fi) Kuivausosa
ID22437A (id) Unit bilah pengaduk
DK0864255T3 (da) Vandkontinuerligt smørbart produkt
FI964809A0 (fi) En utrustning foer tillverkning av taeckplaot
DK0830828T3 (da) Udstillingsvæg
KR960009741U (ko) 다용도 신발
NO964376D0 (no) Skosåle
KR960005657U (ko) 천정매입등
KR940021953U (ko) 휴지걸이
KR960019736U (ko) 구두바닥의 구조
BR9605327A (pt) Microdispositivo eletroepidermico bionizador do ser humano
ITAP960005A1 (it) Lo stadio del 2000
KR970031955U (ko) 버스의 실내손잡이
KR970053265U (ko) 이동용 가방의 받침대
FI963387A0 (fi) Foerfarande foer framstaellning av en elledande produkt
BR9302628A (pt) Compressor cardíaco direto
DK139993D0 (da) Produkt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee